Similar Stories to Abbvie Q1 Global Humira Revenue Down 5.6% To $4.45 Bln; Factset Consensus $4.40 Bln on Bing News

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.

Topics:  real-time   delivered   news   breaking   
BING NEWS:
  • AbbVie's tight grip on Humira market raises concerns about biosimilars
    , opens new tab top-selling arthritis drug Humira has held onto more than 80% of patients after facing nine lower-priced rivals in the U.S. in the last year, raising questions about whether the ...
    06/7/2024 - 4:23 am | View Link
  • AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst
    Cantor Fitzgerald has initiated coverage on AbbVie Inc (NYSE:ABBV), a global pharma company. The analyst notes that the company has positioned itself to absorb Humira biosimilar erosion and ...
    05/17/2024 - 2:46 am | View Link
  • How Far Will AbbVie's Humira Revenue Fall in 2023?
    The world's best-selling drug begins losing patent protections next year. AbbVie's revenue could take years to recover. Of course, all good things must come to an end. Wall Street analysts expect ...
    10/1/2022 - 9:33 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News